Page 23 - Zyme Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Avacta Group PLC, Change of Nominated Adviser

The FDA Expands Collaboration With CN Bio to Investigate Lung-on-a-chip Model for Inhaled Drug Evaluation Applications Follows success of initial project demonstrating the advanced performance of the Company's liver-on-a-chip platform CN Bio, a leading developer of single- and multi-organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today announced the U.S. Food and Drug Administration (FDA) has extended their research collaboration, for a further three years. The scope of the research carried out with the FDA's Center for Drug Evaluati...

Mogrify Completes Series A Financing Totaling $33 Million USD Second close of $17 million USD brings total raised in Series A to $33 million USD Funding led by Parkwalk Advisors with participation from strategic investor: Astellas Venture Management, as well as 24Haymarket, Dr Jonathan Milner and Dr Darrin M Disley OBE Funding will support advancement of immuno-oncology and ophthalmology programs through to IND-enabling studies, as well as continued platform development and exploration of cell reprogramming for novel therapeutic application Appointment of Dr Lorenz Mayr to the Board of Direct...

Investegate announcements from Avacta Group PLC, Issue of Equity

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test 1 up to 31 in early May, followed immediately by commercial launch in Europe Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer and pre|CISION platforms, is pleased to announce positive data from the clinical validation of its AffiDX SARS-CoV-2 antigen lateral flow test. Data from the clinical study conducted in Europe on 98 positive COVID-19 samples demonstrate excellent performance in identifying the SARS-CoV-2 virus across a broad rang...